Anavex Life Sciences Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
14 Jun 24 | BuyUS$10,319 | Peter Donhauser | Individual | 2,835 | US$3.64 | |
15 May 24 | BuyUS$22,600 | Steffen Thomas | Individual | 5,000 | US$4.52 |
Insider Trading Volume
Insider Buying: AVXL insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 745 | 0.00088% |
Individual Insiders | 2,589,631 | 3.06% |
Institutions | 31,972,157 | 37.8% |
General Public | 50,079,004 | 59.2% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 4.7%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
7,299,007 | US$27.9m | 100% | no data | |||
6,645,538 | US$25.4m | -0.38% | no data | |||
4,414,682 | US$16.9m | 1.24% | no data | |||
1,712,727 | US$6.5m | 2.84% | no data | |||
1,306,458 | US$5.0m | 0% | no data | |||
1,250,210 | US$4.8m | 0% | no data | |||
851,128 | US$3.3m | 315% | no data | |||
836,730 | US$3.2m | 4.81% | 0.27% | |||
804,642 | US$3.1m | 675% | 0.01% | |||
718,755 | US$2.7m | -3.06% | no data | |||
669,945 | US$2.6m | 189% | 0.01% | |||
630,067 | US$2.4m | 1.25% | no data | |||
571,645 | US$2.2m | 457% | no data | |||
535,547 | US$2.0m | 1,050% | 0.01% | |||
512,407 | US$2.0m | 69.6% | no data | |||
457,321 | US$1.7m | 143% | no data | |||
370,400 | US$1.4m | 0% | 0.05% | |||
302,060 | US$1.2m | -58.1% | no data | |||
264,257 | US$1.0m | 10.6% | no data | |||
263,989 | US$1.0m | -32.9% | no data | |||
239,661 | US$915.5k | -6.42% | no data | |||
161,500 | US$616.9k | 0% | no data | |||
112,252 | US$428.8k | -46.7% | no data | |||
103,038 | US$393.6k | 169% | 0.02% | |||
102,996 | US$393.4k | 2.56% | no data |